EODData

NASDAQ, KLRS: Kalaris Therapeutics Inc

16 Jan 26 15:59
LAST:

9.765

CHANGE:
 0.88
OPEN:
8.700
HIGH:
9.960
ASK:
0.000
VOLUME:
77.9K
CHG(%):
9.93
PREV:
8.860
LOW:
8.604
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Jan 268.7009.9608.6009.740111.5K
15 Jan 269.1609.3708.8008.86089.4K
14 Jan 269.3509.3908.7379.24045.8K
13 Jan 268.8509.4608.6919.24047.6K
12 Jan 269.7609.9708.7208.840174.1K
09 Jan 268.37010.2438.3009.780238.5K
08 Jan 268.8208.9608.2608.26045.2K
07 Jan 268.5309.0918.4008.76086.8K
06 Jan 268.1408.4188.0258.26083.6K
05 Jan 268.4308.8807.9158.180109.1K

PROFILE

Name:Kalaris Therapeutics Inc
About:Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.
Sector:Healthcare
Industry:Biotechnology
Address:628 Middlefield Road, Palo Alto, CA, United States, 94301
Website:https://kalaristx.com
FIGI:BBG00P80SH34

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-6.35 
Forward P/E:-3.53 
PEG Ratio:-0.03 
Price to Book:3.91 
Return on Assets:-4.41 
Return on Equity:0.33 
EPS Ratio:-40.35 
Shares:18.7M 
Market Cap:182.63M 

TECHNICAL INDICATORS

MA5:9.186.3%
MA10:8.929.5%
MA20:9.087.6%
MA50:7.4730.8%
MA100:6.1858.0%
MA200:4.9099.3%
STO9:74.65
STO14:75.63
RSI14:53.79
WPR14:-2.50 
MTM14:0.61
ROC14:0.07 
ATR:0.90 
Week High:10.244.9%
Week Low:8.3017.7%
Month High:11.8821.7%
Month Low:7.9299.3%

RECENT SPLITS

Date Ratio
16 Jan 20251-23